These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37522711)

  • 1. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
    Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
    Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia.
    Yang K; Xu J; Liu Q; Li J; Xi Y
    Pathol Res Pract; 2019 Feb; 215(2):265-271. PubMed ID: 30466764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
    Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
    Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
    Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
    Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA; Baergen RN; Warnke RA
    Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
    Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
    Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
    Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous involvement in lymphoblastic lymphoma.
    Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
    J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
    Kroeze E; Loeffen JLC; Poort VM; Meijerink JPP
    Blood Adv; 2020 Jul; 4(14):3466-3473. PubMed ID: 32722786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
    Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
    Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
    Huang YH; Wan CL; Dai HP; Xue SL
    Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
    Lin P; Jones D; Dorfman DM; Medeiros LJ
    Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma.
    Satoh T; Kayano H; Kohri M; Tanae K; Asou C; Takahashi N; Tsukasaki K; Yasuda M
    J Clin Exp Hematop; 2023; 63(4):257-261. PubMed ID: 38148016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.